Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Lancet Haematol. 2018 Nov;5(11):e532–e542. doi: 10.1016/S2352-3026(18)30156-X

Figure 4: Outcomes by HCT-CI and DRI, univariate estimates:

Figure 4:

(a) non-relapse mortality by HCT-CI, (b) overall survival by HCT-CI, and (c) overall survival by DRI. The numbers below figures 4b and 4c denote total number of patients at risk (number censored)